Evidence map›Paper›PMID 35096967›Full record

ArticleFrontiers in molecular biosciences2021

A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer.

Ping Lu, Yifei Ma, Jindan Kai, Jun Wang, Zhucheng Yin, Hongli Xu, Xinying Li, Xin Liang, Shaozhong Wei, Xinjun Liang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ping LuDepartment of Medical Oncology, Hubei Cancer Hospital, Wuhan, China.
Yifei MaDepartment of Gastrointestinal Oncology Surgery, Hubei Cancer Hospital, Wuhan, China.
Jindan KaiDepartment of Thoracic Surgery, Hubei Cancer Hospital, Wuhan, China.
Jun WangDepartment of Medical Oncology, Hubei Cancer Hospital, Wuhan, China.
Zhucheng YinDepartment of Medical Oncology, Hubei Cancer Hospital, Wuhan, China.
Hongli XuDepartment of Medical Oncology, Hubei Cancer Hospital, Wuhan, China.
Xinying LiDepartment of Epidemiology and Biostatistics, The Ministry of Education Key Lab of Environment and Health, School of Public Health, Huazhong University of Science and Technology, Wuhan, China.
Xin LiangDepartment of Gastrointestinal Oncology Surgery, Hubei Cancer Hospital, Wuhan, China.
Shaozhong WeiDepartment of Gastrointestinal Oncology Surgery, Hubei Cancer Hospital, Wuhan, China.
Xinjun LiangDepartment of Medical Oncology, Hubei Cancer Hospital, Wuhan, China.
Hubei Cancer Hospital · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced lung cancer inflammation indexinflammationnon–small cell lung canceroverall survivalprognosis

Identifiers

PMID35096967
PMCPMC8795874
OpenAlexW4205593010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.